Lv12
70 积分 2024-04-09 加入
Breast cancer
1天前
待确认
Anlotinib plus penpulimab plus chemo-less therapy in first-line treatment for persistent, recurrent, or metastatic cervical cancer: A single-arm, phase II study (ALTN-AK105-II-06)
3天前
已完结
Second cancer incidence in CLL patients receiving BTK inhibitors
17天前
已完结
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
18天前
已完结
Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer
29天前
已完结
Response and Survival Rates in Patients with Peripheral T-Cell Lymphoma Treated with Anthracycline-Based Regimens: A Comprehensive Meta-Analysis
30天前
已关闭
Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE
2个月前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2个月前
已完结
Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trial
3个月前
已完结
Delayed cardiotoxicity following osimertinib therapy in non-small cell lung cancer: a unique case report
3个月前
已完结
皖公网安备34019202002308
